Fibrosis and adipose tissue dysfunction

Kai Sun, Joan Tordjman, Karine Clément, Philipp E. Scherer

Research output: Contribution to journalArticle

286 Citations (Scopus)

Abstract

Fibrosis is increasingly appreciated as a major player in adipose tissue dysfunction. In rapidly expanding adipose tissue, pervasive hypoxia leads to an induction of HIF1a that in turn leads to a potent profibrotic transcriptional program. The pathophysiological impact of adipose tissue fibrosis is likely to play an equally important role on systemic metabolic alterations as fibrotic conditions play in the liver, heart, and kidney. Here, we discuss recent advances in our understanding of the genesis, modulation, and systemic impact of excessive extracellular matrix (ECM) accumulation in adipose tissue of both rodents and humans and the ensuing impact on metabolic dysfunction.

Original languageEnglish (US)
Pages (from-to)470-477
Number of pages8
JournalCell Metabolism
Volume18
Issue number4
DOIs
StatePublished - Oct 1 2013

Fingerprint

Adipose Tissue
Fibrosis
Extracellular Matrix
Rodentia
Kidney
Liver

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Physiology

Cite this

Fibrosis and adipose tissue dysfunction. / Sun, Kai; Tordjman, Joan; Clément, Karine; Scherer, Philipp E.

In: Cell Metabolism, Vol. 18, No. 4, 01.10.2013, p. 470-477.

Research output: Contribution to journalArticle

Sun, K, Tordjman, J, Clément, K & Scherer, PE 2013, 'Fibrosis and adipose tissue dysfunction', Cell Metabolism, vol. 18, no. 4, pp. 470-477. https://doi.org/10.1016/j.cmet.2013.06.016
Sun, Kai ; Tordjman, Joan ; Clément, Karine ; Scherer, Philipp E. / Fibrosis and adipose tissue dysfunction. In: Cell Metabolism. 2013 ; Vol. 18, No. 4. pp. 470-477.
@article{277f54db354a415bb952a4489f81cf7b,
title = "Fibrosis and adipose tissue dysfunction",
abstract = "Fibrosis is increasingly appreciated as a major player in adipose tissue dysfunction. In rapidly expanding adipose tissue, pervasive hypoxia leads to an induction of HIF1a that in turn leads to a potent profibrotic transcriptional program. The pathophysiological impact of adipose tissue fibrosis is likely to play an equally important role on systemic metabolic alterations as fibrotic conditions play in the liver, heart, and kidney. Here, we discuss recent advances in our understanding of the genesis, modulation, and systemic impact of excessive extracellular matrix (ECM) accumulation in adipose tissue of both rodents and humans and the ensuing impact on metabolic dysfunction.",
author = "Kai Sun and Joan Tordjman and Karine Cl{\'e}ment and Scherer, {Philipp E.}",
year = "2013",
month = "10",
day = "1",
doi = "10.1016/j.cmet.2013.06.016",
language = "English (US)",
volume = "18",
pages = "470--477",
journal = "Cell Metabolism",
issn = "1550-4131",
publisher = "Cell Press",
number = "4",

}

TY - JOUR

T1 - Fibrosis and adipose tissue dysfunction

AU - Sun, Kai

AU - Tordjman, Joan

AU - Clément, Karine

AU - Scherer, Philipp E.

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Fibrosis is increasingly appreciated as a major player in adipose tissue dysfunction. In rapidly expanding adipose tissue, pervasive hypoxia leads to an induction of HIF1a that in turn leads to a potent profibrotic transcriptional program. The pathophysiological impact of adipose tissue fibrosis is likely to play an equally important role on systemic metabolic alterations as fibrotic conditions play in the liver, heart, and kidney. Here, we discuss recent advances in our understanding of the genesis, modulation, and systemic impact of excessive extracellular matrix (ECM) accumulation in adipose tissue of both rodents and humans and the ensuing impact on metabolic dysfunction.

AB - Fibrosis is increasingly appreciated as a major player in adipose tissue dysfunction. In rapidly expanding adipose tissue, pervasive hypoxia leads to an induction of HIF1a that in turn leads to a potent profibrotic transcriptional program. The pathophysiological impact of adipose tissue fibrosis is likely to play an equally important role on systemic metabolic alterations as fibrotic conditions play in the liver, heart, and kidney. Here, we discuss recent advances in our understanding of the genesis, modulation, and systemic impact of excessive extracellular matrix (ECM) accumulation in adipose tissue of both rodents and humans and the ensuing impact on metabolic dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=84885180828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885180828&partnerID=8YFLogxK

U2 - 10.1016/j.cmet.2013.06.016

DO - 10.1016/j.cmet.2013.06.016

M3 - Article

VL - 18

SP - 470

EP - 477

JO - Cell Metabolism

JF - Cell Metabolism

SN - 1550-4131

IS - 4

ER -